Tissue- and isoform-specific effects of aging in rats on protein kinase C in insulin-sensitive tissues

1999 ◽  
Vol 97 (3) ◽  
pp. 355-361 ◽  
Author(s):  
Xianqin QU ◽  
J. Paul SEALE ◽  
Richard DONNELLY

The mechanisms responsible for the age-related decline in insulin sensitivity have not been clearly identified, but activation of the diacylglycerol/protein kinase C (PKC) signalling pathway (often confined to individual isoforms of PKC) has recently been implicated in the pathogenesis of other insulin-resistant states in both humans and animal models. Fasting serum glucose, insulin and triacylglycerol (triglyceride) concentrations, and results of oral glucose tolerance tests, were compared in groups of 6-week-old (n = 8) and 6-month-old (n = 8) Sprague–Dawley rats. Insulin-responsive tissues (liver, soleus muscle and epididymal fat pad) were collected to compare levels of diacylglycerol, PKC enzyme activity and protein expression of individual PKC isoforms in cytosol and membrane fractions. The older group were heavier (556±14 g, compared with 188±7 g) and relatively insulin-resistant and hyperinsulinaemic (477±73 pM compared with 293±51 pM; P < 0.05) compared with young rats; they also had greater areas under the serum glucose (old, 20.3±1.1; young, 17.3±0.7 mmol·h-1·l-1) and insulin (old, 1254±76; young, 721±113 mmol·h-1·l-1) profiles following an oral glucose tolerance test, and significantly higher fasting triacylglycerol levels (old, 1.24±0.06 mM; young, 0.92±0.07 mM; P < 0.01). There were no age-related differences in diacylglycerol levels or PKC activity in muscle and liver, but membrane-associated PKC activity was 2.5-fold higher in the adipose tissue of older rats (101±19 compared with 40±5 pmol·min-1·mg-1 protein; P < 0.05) due to increased translocation of PKC-βI, -βII and -ε. Thus insulin resistance due to normal aging is associated with tissue- and isoform-specific changes in diacylglycerol/PKC signalling. In contrast with diabetes and dietary-induced insulin resistance, there were no changes in diacylglycerol/PKC signalling in skeletal muscle and liver, but isoform-specific translocation and higher PKC activity in adipose tissue may blunt the insulin-mediated inhibition of lipolysis and contribute to the increased triacylglycerol levels observed in older animals.

2005 ◽  
Vol 33 (2) ◽  
pp. 350-353 ◽  
Author(s):  
R.V. Farese ◽  
M.P. Sajan ◽  
M.L. Standaert

It now seems clear that aPKC (atypical protein kinase C) isoforms are required for insulin-stimulated glucose transport in muscle and adipocytes. Moreover, there are marked defects in the activation of aPKCs under a variety of insulin-resistant conditions in humans, monkeys and rodents. In humans, defects in aPKC in muscle are seen in Type II diabetes and its precursors, obesity, the obesity-associated polycystic ovary syndrome and impaired glucose tolerance. These defects in muscle aPKC activation are due to both impaired activation of insulin receptor substrate-1-dependent PI3K (phosphoinositide 3-kinase) and the direct activation of aPKCs by the lipid product of PI3K, PI-3,4,5-(PO4)3. Although it is still uncertain which underlying defect comes first, the resultant defect in aPKC activation in muscle most certainly contributes significantly to the development of skeletal muscle insulin resistance. Of further note, unlike the seemingly ubiquitous presence of defective aPKC activation in skeletal muscle in insulin-resistant states, the activation of aPKC is normal or increased in livers of Type II diabetic and obese rodents. The maintenance of aPKC activation in the liver may explain how insulin-dependent lipid synthesis is maintained in these states, as aPKCs function mainly in the activation of enzymes important for lipid synthesis. Thus increased activation of liver aPKC in hyperinsulinaemic states may contribute significantly to the development of hyperlipidaemia in insulin-resistant states.


2001 ◽  
Vol 13 (3) ◽  
pp. 169-175 ◽  
Author(s):  
Kazuo Kajita ◽  
Tatsuo Ishizuka ◽  
Atsushi Miura ◽  
Yoshinori Kanoh ◽  
Masayoshi Ishizawa ◽  
...  

2019 ◽  
Vol 29 (1) ◽  
pp. 183-191.e7 ◽  
Author(s):  
Amanda E. Brandon ◽  
Bing M. Liao ◽  
Barbara Diakanastasis ◽  
Benjamin L. Parker ◽  
Katy Raddatz ◽  
...  

Metabolism ◽  
2009 ◽  
Vol 58 (1) ◽  
pp. 109-119 ◽  
Author(s):  
Wei-Jia Kong ◽  
Hao Zhang ◽  
Dan-Qing Song ◽  
Rong Xue ◽  
Wei Zhao ◽  
...  

1997 ◽  
Vol 273 (5) ◽  
pp. E915-E921 ◽  
Author(s):  
Carsten Schmitz-Peiffer ◽  
Nicholas D. Oakes ◽  
Carol L. Browne ◽  
Edward W. Kraegen ◽  
Trevor J. Biden

We have recently shown that the reduction in insulin sensitivity of rats fed a high-fat diet is associated with the translocation of the novel protein kinase Cε(nPKCε) from cytosolic to particulate fractions in red skeletal muscle and also the downregulation of cytosolic nPKCθ. Here we have further investigated the link between insulin resistance and PKC by assessing the effects of the thiazolidinedione insulin-sensitizer BRL-49653 on PKC isoenzymes in muscle. BRL-49653 increased the recovery of nPKC isoenzymes in cytosolic fractions of red muscle from fat-fed rats, reducing their apparent activation and/or downregulation, whereas PKC in control rats was unaffected. Because BRL-49653 also improves insulin-stimulated glucose uptake in fat-fed rats and reduces muscle lipid storage, especially diglyceride content, these results strengthen the association between lipid availability, nPKC activation, and skeletal muscle insulin resistance and support the hypothesis that chronic activation of nPKC isoenzymes is involved in the generation of muscle insulin resistance in fat-fed rats.


2003 ◽  
Vol 4 (2) ◽  
pp. 92
Author(s):  
R. Farese ◽  
M. Standaert ◽  
M. Sajan ◽  
A. Miura ◽  
R. Lea-Currie ◽  
...  

2013 ◽  
Vol 113 (4) ◽  
pp. 418-427 ◽  
Author(s):  
Qian Li ◽  
Kyoungmin Park ◽  
Chenzhong Li ◽  
Christian Rask-Madsen ◽  
Akira Mima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document